Skip to main content
Clinical Trials/ACTRN12610000221055
ACTRN12610000221055
Completed
未知

Patients with atrial fibrillation undergoing a disease-specific patient management intervention programme compared to standard care for the optimisation of health and well-being

Baker IDI Heart & Diabetes Institute0 sites335 target enrollmentMarch 17, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Baker IDI Heart & Diabetes Institute
Enrollment
335
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 17, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Baker IDI Heart & Diabetes Institute

Eligibility Criteria

Inclusion Criteria

  • 1\. Documented diagnosis of sustained form of non\-valvular atrial fibrillation
  • 2\. A minimum of one hospitalisation (including index admission) related, at least in part, to atrial fibrillation
  • 3\. Are living independently in the community or their own home post\-hospitalisation
  • 4\. Are able and willing to provide written informed consent to participate in the trial

Exclusion Criteria

  • 1\. Aged below 45 years
  • 2\. Have a diagnosis of valvular atrial fibrillation
  • 3\. Are scheduled for a catheter ablation for treatment of atrial fibrillation
  • 4\. Have evidence of pre\-existing New York Heart Association (NYHA) Class III\-IV with a documented left ventricular ejection fraction less than 45%
  • 5\. Have alcohol\-induced atrial fibrillation
  • 6\. Have transient forms of atrial fibrillation associated with acute myocardial infarction and/or pericarditis
  • 7\. Have a terminal condition or malignancy requiring palliative care
  • 8\. Cannot adequately provide written informed consent to participate
  • 9\. Have any other medical condition that results in the belief that it is not appropriate for the patient to embark on participation within this study

Outcomes

Primary Outcomes

Not specified

Similar Trials